GSK Annual Report 2002
GSK Annual Report 2002
GSK Annual Report 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
146 GlaxoSmithKline Financial record<br />
Pharmaceutical sales – Europe Q4 <strong>2002</strong> Q3 <strong>2002</strong> Q2 <strong>2002</strong> Q1 <strong>2002</strong><br />
£m CER % £m CER % £m CER % £m CER %<br />
CNS 207 (4) 183 (1) 194 (4) 186 –<br />
Depression 101 (2) 87 (3) 99 (1) 88 (1)<br />
Seroxat/Paxil 101 (2) 87 (3) 99 (1) 88 (1)<br />
Wellbutrin – – – – – – – –<br />
Migraine 41 (11) 39 (1) 39 (9) 42 9<br />
Imigran/Imitrex 35 (10) 32 – 32 (10) 34 8<br />
Naramig/Amerge 6 (16) 7 (3) 7 (4) 8 12<br />
Lamictal 44 11 37 6 35 (1) 35 14<br />
Requip 10 (3) 9 – 10 9 9 11<br />
Zyban 7 (37) 6 (14) 5 (35) 9 (47)<br />
Respiratory 364 4 309 – 344 4 324 7<br />
Seretide/Advair,<br />
Flixotide/Flovent, Serevent 279 8 237 3 258 9 244 13<br />
Seretide/Advair 168 23 146 19 153 45 141 69<br />
Flixotide/Flovent 60 (10) 48 (16) 55 (24) 56 (20)<br />
Serevent 51 (7) 43 (13) 50 (15) 47 (25)<br />
Flixonase/Flonase 12 (3) 11 (6) 16 (12) 13 2<br />
Ventolin 37 (1) 30 (1) 33 (7) 33 2<br />
Becotide 27 (13) 25 (13) 27 (12) 26 (19)<br />
Anti-virals 176 10 150 4 158 6 152 6<br />
HIV 130 20 107 8 115 9 110 14<br />
Combivir 52 14 43 – 46 (4) 45 (5)<br />
Trizivir 32 76 24 64 25 >100 22 >100<br />
Epivir 26 7 21 (4) 24 (4) 23 (7)<br />
Retrovir 4 (16) 2 (71) 5 8 6 20<br />
Ziagen 14 1 15 25 12 (8) 12 (8)<br />
Agenerase 2 11 2 – 3 7 2 35<br />
Herpes 35 (14) 34 (8) 37 (3) 34 (20)<br />
Valtrex 19 (10) 18 12 20 38 16 (12)<br />
Zovirax 16 (19) 16 (23) 17 (28) 18 (26)<br />
Zeffix 4 16 4 47 4 21 4 58<br />
Anti-bacterials 193 (7) 146 (2) 163 (4) 194 6<br />
Augmentin 86 (9) 65 (4) 73 (5) 91 4<br />
Zinnat/Ceftin 35 (12) 22 – 27 (12) 33 5<br />
Fortum 25 (8) 21 3 24 3 26 20<br />
Amoxil 12 (18) 10 (10) 10 (13) 13 (8)<br />
Metabolic and gastro-intestinal 60 (28) 53 (23) 62 (18) 66 (12)<br />
Avandia 12 15 9 25 11 38 10 52<br />
Zantac 29 (34) 25 (31) 29 (32) 33 (22)<br />
Vaccines 127 24 137 31 111 4 93 8<br />
Hepatitis 52 5 53 14 54 13 45 9<br />
Infanrix 33 14 29 35 30 (28) 25 (3)<br />
Oncology and emesis 39 3 38 8 38 6 37 5<br />
Zofran 29 2 30 10 30 8 28 8<br />
Hycamtin 7 9 5 2 6 (2) 6 1<br />
Cardiovascular 39 3 35 17 39 (2) 34 15<br />
Coreg – – – – – – – –<br />
Arthritis (Relafen) 1 (31) 1 (60) 3 (16) 1 (44)<br />
Other 66 7 55 (2) 62 14 61 3<br />
Total pharmaceutical sales 1,272 1 1,107 2 1,174 1 1,148 4
Change language